OTCMKTS:SNWV - SANUWAVE Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.17 0.00 (0.00 %)
(As of 05/19/2019 02:37 AM ET)
Previous Close$0.17
Today's Range$0.1650 - $0.1788
52-Week Range$0.1353 - $0.45
Volume75,529 shs
Average Volume434,128 shs
Market Capitalization$29.09 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.72
SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications worldwide. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead product candidate is the dermaPACE device, which has completed its initial Phase III, IDE clinical trial for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. It markets and sells its devices and accessories. SANUWAVE Health, Inc. was founded in 2005 and is headquartered in Suwanee, Georgia.

Receive SNWV News and Ratings via Email

Sign-up to receive the latest news and ratings for SNWV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SNWV
CUSIPN/A
CIKN/A
Phone770-419-7525

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.85 million
Book Value($0.10) per share

Profitability

Net Income$-11,630,000.00
Net Margins-628.70%

Miscellaneous

Employees14
Market Cap$29.09 million
Next Earnings Date5/22/2019 (Estimated)
OptionableNot Optionable

SANUWAVE Health (OTCMKTS:SNWV) Frequently Asked Questions

What is SANUWAVE Health's stock symbol?

SANUWAVE Health trades on the OTCMKTS under the ticker symbol "SNWV."

How were SANUWAVE Health's earnings last quarter?

SANUWAVE Health, Inc. (OTCMKTS:SNWV) posted its quarterly earnings data on Friday, March, 29th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.02) by $0.01. The firm had revenue of $0.46 million for the quarter, compared to the consensus estimate of $0.47 million. View SANUWAVE Health's Earnings History.

When is SANUWAVE Health's next earnings date?

SANUWAVE Health is scheduled to release their next quarterly earnings announcement on Wednesday, May 22nd 2019. View Earnings Estimates for SANUWAVE Health.

Has SANUWAVE Health been receiving favorable news coverage?

News headlines about SNWV stock have trended negative on Sunday, according to InfoTrie. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. SANUWAVE Health earned a daily sentiment score of -2.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days.

Who are some of SANUWAVE Health's key competitors?

What other stocks do shareholders of SANUWAVE Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SANUWAVE Health investors own include Biocept (BIOC), Juniper Pharmaceuticals (JNP), First Majestic Silver (FR), Arca Biopharma (ABIO), Amgen (AMGN), Amarin (AMRN), Bellicum Pharmaceuticals (BLCM), CytRx (CYTR), Exelixis (EXEL) and Amicus Therapeutics (FOLD).

Who are SANUWAVE Health's key executives?

SANUWAVE Health's management team includes the folowing people:
  • Mr. Kevin A. Richardson II, Chairman & CEO (Age 51)
  • Mr. Shri P. Parikh, Pres (Age 47)
  • Ms. Lisa E. Sundstrom, Chief Financial Officer (Age 50)
  • Mr. Peter Stegagno, Chief Operating Officer (Age 59)
  • Dr. Iulian Cioanta, Chief Science & Technology Officer (Age 56)

How do I buy shares of SANUWAVE Health?

Shares of SNWV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SANUWAVE Health's stock price today?

One share of SNWV stock can currently be purchased for approximately $0.17.

How big of a company is SANUWAVE Health?

SANUWAVE Health has a market capitalization of $29.09 million and generates $1.85 million in revenue each year. The company earns $-11,630,000.00 in net income (profit) each year or ($0.08) on an earnings per share basis. SANUWAVE Health employs 14 workers across the globe.

What is SANUWAVE Health's official website?

The official website for SANUWAVE Health is http://www.sanuwave.com.

How can I contact SANUWAVE Health?

SANUWAVE Health's mailing address is 3360 MARTIN FARM ROAD SUITE 100, Suwanee GA, 30024. The company can be reached via phone at 770-419-7525 or via email at [email protected]


MarketBeat Community Rating for SANUWAVE Health (OTCMKTS SNWV)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  74 (Vote Outperform)
Underperform Votes:  67 (Vote Underperform)
Total Votes:  141
MarketBeat's community ratings are surveys of what our community members think about SANUWAVE Health and other stocks. Vote "Outperform" if you believe SNWV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNWV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/19/2019 by MarketBeat.com Staff

Featured Article: Discount Rate

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel